← boothcheck

Is BAC overvalued?

boothcheck doesn't label BAC overvalued or undervalued and publishes no house fair value, target price, or buy/sell rating. Individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. In the published model solve dated 2026-08-30T04:06:24.299Z, anchored at $62.30, BAC is priced for growth of +13.7% sustained for about 28 years. The price is supported by asset-based value. A value/asset-supported name, not a pure growth bet. The report narrative was composed 2026-08-07. The more the price assumes beyond what BofA Finance LLC has actually delivered, the more has to go right to justify it. Whether that bar is too high is your call, and the full bull and bear cases are in the report.

Derived from BofA Finance LLC's SEC EDGAR filings via a reverse-DCF inversion. Last analyzed August 7, 2026.

Implied growth+13.7%
For about28 yrs
Held margin (input)
Margin today
Price vs asset value1.09x
Price vs earnings power1.33x
Read the full BAC report →
Get boothcheck's read on what BAC's price is betting on, in your inbox when it moves. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.